Abstract: The present disclosure relates to methods of treating a cancer in a subject in need thereof, comprising administering a therapeutically effective amount of a Seneca Valley Virus (SVV) or a polynucleotide encoding the SVV viral genome to the subject, wherein the cancer is classified as sensitive to SVV infection based on the expression level of one or more genes in the cancer. Methods of selecting subjects for treatment are also provided herein.